Mission Doing now what patients need next We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world.
That is why we come to work each day. We commit ourselves to scientific rigour, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow.
We are proud of who we are, what we do, and how we do it. We are many, working as one across functions, across companies, and across the world.
We are Roche.
Description Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders.
At Grifols, what we do is important.
Are you passionate about making a difference in the world? At Grifols, we are pioneers in the development of therapies derived from blood and plasma. We are helping to build the future of the healthcare sector to improve people's well-being. Since 1909, we have been defined by passion, innovation, teamwork and a sense of responsibility. Our people change lives while growing and developing in a forward-looking international company.
Founded by Masco Corporation in 1954 with the introduction of the single-handle faucet, Delta Faucet Company is proud to be America's faucet innovation leader, featuring Delta®, Brizo® and Peerless® products. A WaterSense® partner of the U.S. Environmental Protection Agency, Delta Faucet is a global organization offering kitchen and bath faucets, showerheads, tub and shower systems, toilets, and related accessories, selling products in more than 53 countries. For more information, visit www.deltafaucetcompany.com.
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop its multi-cancer early detection blood test. GRAIL has locations in Menlo Park, California Raleigh / Durham NC, Washington DC and the UK. For more information, please visit www.grail.com
Miltenyi Biotec is a global leader in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cutting-edge cell and gene therapy. Starting with our proprietary magnetic-activated cell sorting (MACS) Technology, Miltenyi provides an innovative portfolio of cellular technologies that can be seamlessly used in a variety of research, translational, and clinical applications.
BioNTech ("Biopharmaceutical New Technologies") is a next generation immunotherapy company pioneering novel therapies for cancer and infectious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer.
Roche has an employee rating of 4.1 out of 5 stars, based on 6,481 company reviews on Glassdoor which indicates that most employees have an excellent working experience there. The Roche employee rating is in line with the average (within 1 standard deviation) for employers within the Pharmaceutical & Biotechnology industry (3.5 stars).
To get a job at Roche, browse currently open positions and apply for a job near you. Once you get a positive response, make sure to find out about the interview process at Roche and prepare for tough questions.
Overall, 81% of employees would recommend working at Roche to a friend. This is based on 8,622 anonymously submitted reviews on Glassdoor.
68% of job seekers rate their interview experience at Roche as positive. Candidates give an average difficulty score of 3 out of 5 (where 5 is the highest level of difficulty) for their job interview at Roche.